Fell, Matthew J. et al
"MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition." Journal of Pharmacology and Experimental Therapeutics
355.3
(2015):
397-409.
Web. 28 Mar. 2024.